Trial site

Fuwai Hospital

Beijing, Beijing Municipality 100037, ChinaNot linked to an institution yet

32running trials
12closed trials

The trials here

What the 44 trials at this site are about, from their registry records.

Conditions: Coronary artery disease16 trials
Atrial fibrillation5 trials
Heart failure5 trials
Aortic stenosis4 trials
Hypertrophic cardiomyopathy4 trials
Congenital heart disease3 trials
High blood pressure3 trials
Stroke2 trials
Amyloidosis1 trial
Aortic aneurysm1 trial
Dilated cardiomyopathy1 trial
Fabry disease1 trial
and 5 more
Phase: Phase 25 trials
Phase 45 trials
Early phase 11 trial
Status: Recruiting23 trials
Completed11 trials
Not yet recruiting5 trials
Active, not recruiting3 trials
Enrolling by invitation1 trial
Terminated1 trial
Lead sponsor: China National Center for Cardiovascular Diseases23 trials
Chinese Academy of Medical Sciences, Fuwai Hospital9 trials
Fu Wai Hospital, Beijing, China3 trials
China-Japan Friendship Hospital1 trial
Eddingpharm (Zhuhai) Co., Ltd.1 trial
and 7 more

Running trials

Not yet recruiting
Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential Hypertension
NCT07932145· Phase 4· China National Center for Cardiovascular Diseases· Source
Contact: Jiali Song, Prof.
Recruiting
PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk
NCT07741253· China National Center for Cardiovascular Diseases· Source
Contact: Zhinan Lu
Not yet recruiting
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT
NCT07762755· Phase 4· China National Center for Cardiovascular Diseases· Source
Contact: Jianing Zhang, Master
Not yet recruiting
The COMBINE-AF Trial
NCT07633509· Yunlong Wang· Source
Contact: Min Tang, PhD
Recruiting
Unipolar Voltage Mapping for Personalized Atrial Fibrillation Ablation
NCT07630857· China National Center for Cardiovascular Diseases· Source
Contact: Jiaju Li
Not yet recruiting
Stepwise vs Standard Anticoagulation for AF Patients Undergoing CIED Implantation (STEP-AF)
NCT07616414· Fu Wai Hospital, Beijing, China· Source
Contact: Xiaofei Li, Dr.
Recruiting
A Dose-exploration Study of EDP167 in HoFH
NCT07489209· Phase 2· Eddingpharm (Zhuhai) Co., Ltd.· Source
Contact: Ethics Committee of Fuwai Hospital
Recruiting
Ademetionine in Obstructive Hypertrophic Cardiomyopathy
NCT07367724· Phase 2· China National Center for Cardiovascular Diseases· Source
Contact: Lei Song
Recruiting
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
NCT06615596· Early phase 1· China National Center for Cardiovascular Diseases· Source
Contact: Ligang Ding, Phd
Enrolling by invitation
A Clinical Study on the Use of the Sentinel Cerebral Protection Device During TAVR for the Prevention of Procedure-Related Stroke
NCT07045233· China National Center for Cardiovascular Diseases· Source
Recruiting
Multi-modal Adverse Events Prediction for Premature Coronary Heart Disease Trial: MAP-CHD Trial
NCT07004452· China National Center for Cardiovascular Diseases· Source
Contact: Jingjing Xu
Recruiting
A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
NCT07318155· Phase 2· Sirius Therapeutics Co., Ltd.· Source
Contact: MD
Active, not recruiting
Artificial Intelligence-assisted Diagnosis
NCT06783933· China National Center for Cardiovascular Diseases· Source
Recruiting
Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis
NCT07316452· Fu Wai Hospital, Beijing, China· Source
Contact: Zhihui Hou, MD，PhD
Recruiting
Transaxillary TAVR With Solely Echocardiography Guidance
NCT07035847· Chinese Academy of Medical Sciences, Fuwai Hospital· Source
Contact: Xiangbin Pan
Active, not recruiting
An Observational Study of Subcutaneous Implantable Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy At High Risk of Sudden Cardiac Death
NCT06604169· China National Center for Cardiovascular Diseases· Source
Recruiting
Modified Aortic Root Enlargement Procedure
NCT06517537· China National Center for Cardiovascular Diseases· Source
Contact: xiaopeng hu
Recruiting
Mobile Internet-based Remote Home Rehabilitation Improves Prognostic Function and Life Quality in Pulmonary Hypertension
NCT06362382· China-Japan Friendship Hospital· Source
Contact: Xiaoming Zhou, MD
Recruiting
A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine
NCT06203873· Chinese Academy of Medical Sciences, Fuwai Hospital· Source
Contact: Xiangbin Pan, MD
Recruiting
Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
NCT06096909· Phase 4· China National Center for Cardiovascular Diseases· Source
Contact: Na-Qiong Wu, Doctor
Recruiting
Post-market European & Asian Registry to Evaluate the Minos™ Stent-Graft and Delivery System in Abdominal Aortic Aneurysm Treatment
NCT07674173· Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd· Source
Contact: Chang Shu (principal investigator)
Active, not recruiting
Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population
NCT05462262· Chinese Academy of Medical Sciences, Fuwai Hospital· Source
Recruiting
Corheart 6: Long-term Cohort Study
NCT07094919· China National Center for Cardiovascular Diseases· Source
Contact: Xianqiang Wang
Recruiting
Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention
NCT04240834· Phase 4· Fu Wai Hospital, Beijing, China· Source
Contact: Haiyan Qian, MD, PhD
Recruiting
Diagnosis and OutcoMes evaluAtIoN of Multicenter Patients With HFpEF Using Multimodality Imaging
NCT04602338· Chinese Academy of Medical Sciences, Fuwai Hospital· Source
Contact: Minjie Lu, PhD
Recruiting
Effects of Left Atrial Appendage Resection and Marshall Ligament Amputation on Clinical Outcome in Patients Undergoing Off-pump Coronary Artery Bypass
NCT04220047· China National Center for Cardiovascular Diseases· Source
Contact: Hansong Sun, doctor
Recruiting
Cardiac Magnetic Resonance for Risk Stratification in Dilated Cardiomyopathy
NCT04990297· Chinese Academy of Medical Sciences, Fuwai Hospital· Source
Contact: Minjie Lu, PhD
Recruiting
Multimodality Imaging in the Screening, Diagnosis and Risk StratifictiON of HFpEF
NCT04603404· Chinese Academy of Medical Sciences, Fuwai Hospital· Source
Contact: Minjie Lu, PhD
Recruiting
VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial
NCT04414878· Shanghai MicroPort CardioFlow Medtech Co., Ltd.· Source
Contact: Yongjian Wu, Prof
Recruiting
Randomization of Single vs Multiple Arterial Grafts
NCT03217006· Weill Medical College of Cornell University· Source
Contact: Zhe Zheng
Recruiting
The Chinese Hypertrophic Cardiomyopathy Study(CHCS)
NCT02696135· China National Center for Cardiovascular Diseases· Source
Contact: Lei Song, MD.& PhD.
Recruiting
Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques
NCT07336394· Chinese Academy of Medical Sciences, Fuwai Hospital· Source
Contact: Minjie Lu MD, PhD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Coronary artery disease8 recruiting
Atrial fibrillation5 recruiting
Aortic stenosis4 recruiting
Heart failure4 recruiting
High blood pressure2 recruiting
Hypertrophic cardiomyopathy2 recruiting
Stroke2 recruiting
Amyloidosis1 recruiting
Aortic aneurysm1 recruiting
Dilated cardiomyopathy1 recruiting
Fabry disease1 recruiting
Familial hypercholesterolaemia1 recruiting
Migraine1 recruiting
Peripheral artery disease1 recruiting
Pulmonary arterial hypertension1 recruiting
Sarcoidosis1 recruiting

Closed trials

Completed
AI-Assisted Coronary Syndrome Subtyping From Admission History of Present Illness: A Clinician Reader Study
NCT07449429· China National Center for Cardiovascular Diseases· Source
Completed
Performance of an OCR-Prompt-LLM Integrated Workflow for Extracting Multi-dimensional Clinical Data in Ischemic Heart Disease
NCT07499830· China National Center for Cardiovascular Diseases· Source
Completed
Scalable Clinical Oversight of Large Language Models Via Uncertainty Triangulation
NCT07414966· China National Center for Cardiovascular Diseases· Source
Completed
A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
NCT06816251· Phase 2· Shandong Suncadia Medicine Co., Ltd.· Source
Terminated
Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis
NCT07187895· Phase 2· Sinotau Pharmaceutical Group· Source
Completed
Retrospective Algorithm Validation of IVUS-FFR in Patients
NCT07551518· China National Center for Cardiovascular Diseases· Source
Completed
Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting
NCT05380063· Phase 4· China National Center for Cardiovascular Diseases· Source
Completed
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
NCT06030596· China National Center for Cardiovascular Diseases· Source
Completed
Baduanjin Lower Elevated Blood PreSsure Study
NCT05397535· China National Center for Cardiovascular Diseases· Source
Completed
"Critical State" Early Warning Score After CHD Surgery and Rapid Response Team
NCT06578312· Chinese Academy of Medical Sciences, Fuwai Hospital· Source
Completed
Incidence and Management of Driveline Infection in Patients with CH-VAD
NCT06878456· China National Center for Cardiovascular Diseases· Source
Completed
The Fate of Aortic Valve After SAS Surgery in Children
NCT06751368· Chinese Academy of Medical Sciences, Fuwai Hospital· Source

Site data: ClinicalTrials.govUpdated 13 Nov 2026

Report an error